TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”
With strong 1-year returns and upside potential, RAPT Therapeutics, Inc. (NASDAQ:RAPT) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026.
December 21st, 2025 - News
December 19th, 2025 - Hedge Funds News
October 26th, 2025 - News
September 24th, 2024 - Hedge Funds News
June 21st, 2024 - Hedge Fund Investor Letters News
March 22nd, 2024 - Hedge Fund Investor Letters News
January 28th, 2022 - Hedge Funds News
November 29th, 2021 - Hedge Funds News
October 29th, 2021 - Hedge Funds News
Returns since its inception in May 2014 (through June 2, 2026)
Subscribe Now30 day money back guarantee. Cancel anytime.
Past performance does not guarantee future returns. Click to see how the portfolio is constructed.